Advances in active surveillance of prostate cancer
10.3760/cma.j.cn112330-20230108-00014
- VernacularTitle:前列腺癌主动监测研究进展
- Author:
Yingsheng LIN
1
;
Zengqin LIU
;
Jing XIE
;
Kefeng XIAO
Author Information
1. 暨南大学第二临床医学院，深圳 518020
- Keywords:
Prostatic neoplasms;
Carcinoma;
Active surveillance;
Biomarkers;
Quality of life
- From:
Chinese Journal of Urology
2023;44(9):717-720
- CountryChina
- Language:Chinese
-
Abstract:
The popularity of prostate-specific antigen screening has led to overdiagnosis and overtreatment of prostate cancer. Active surveillance can be used as a safe and reliable treatment option for some patients with localized prostate cancer. At the same time, compared with surgery and chemoradiotherapy, active surveillance can provide these patients with a better quality of life. A variety of new monitoring methods, including PSMA PET and biomarkers, can optimize the risk stratification of prostate cancer and reduce unnecessary puncture biopsies to further improve the quality of life of patients. However, there are still great controversies about the inclusion criteria, monitoring programs, and intervention indications for active surveillance of prostate cancer, and domestic doctors and patients still lack acceptance of it. This article reviews the research progress of active surveillance in prostate cancer.
